Zeitschrift für Gastroenterologie, Table of Contents Z Gastroenterol 2001; 39(1): 51-54DOI: 10.1055/s-2001-10700 Leitlinien der DGVS© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New YorkKarzinomprophylaxeR. Porschen Bremen Recommend Article Abstract Buy Article Full Text References Literatur 1 Gilat T, Fireman Z, Grossman A. et al . Colorectal cancer in patients with ulcerative colitis. Gastroenterology. 1988; 94 870-877 (III) 2 Gyde S N, Prior P, Allan R N. et al . Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres. Gut. 1988; 29 206-217 (III) 3 Eaden J A, Abrams K, Mayberry J F. The true risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gastroenterology. 1999; 116 A 397 (I a) 4 Ekbom A, Helmick C, Zack M. et al . Ulcerative colitis and colorectal cancer. N Engl J Med. 1990; 323 1228-1233 (II b) 5 Haens G R, Lashner B A, Hanauer S B. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol. 1993; 88 1174-1178 (III) 6 Broome U, Löfberg R, Veress B. et al . Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential. Hepatology. 1995; 22 1404-1408 (II b) 7 Brentnall T A, Haggitt R C, Rabinovitch P S. et al . Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996; 110 331-338 (II b) 8 Porschen R, Holzmann K, Klump B. et al .The role of flow cytometry in surveillance strategies in patients with ulcerative colitis. Emmrich J, Liebe S, Stange EF Kluwer Academic Publishers Innovative concepts in inflammatory bowel disease Boston, London; 1999 II a: 43-253 9 Heuschen U A, Heuschen G, Stern J. et al .Backwash ileitis in ulcerative colitis - new aspects in the assessment of the disease. Andus T, Goebell H, Layer P, Schölmerich J Kluwer Academic Publishers Inflammatory bowel diseases - from bench to bedside Dordrecht, Boston, London; 1997 III: 245-249 10 Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol. 1996; 91 44-48 (III) 11 Biasco G, Zannoni U, Paganelli G M. et al . Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev. 1997; 6 469-471 (I b) 12 Lashner B A, Provencher K S, Seidner D L. et al . The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology. 1997; 112 29-32 (III) 13 Fiedler L, Rubin P, Korelitz B. et al . Does folate (f) supplementation really protect from dysplasia and cancer in ulcerative colitis (uc)? A case control study. Gastroenterology. 1993; 104 A-546 (III) 14 Greenstein A J, Sachar D B, Smith H. et al . Cancer in universal and left-sided ulcerative colitis: Factors determining risk. Gastroenterology. 1979; 77 290-294 (II a) 15 Sugita A, Sachar D B, Bodian C. et al . Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut. 1991; 32 167-169 (III) 16 Pinczowski D, Ekbom A, Baron J. et al . Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study. Gastroenterology. 1994; 107 117-120 (III) 17 Moody G A, Jayanthi V, Probert C SJ. et al . Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: A retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol. 1996; 8 1179-1183 (II b) 18 Mellemkjaer L, Olsen J H, Frisch M. et al . Cancer in patients with ulcerative colitis. Int J Cancer. 1995; 60 330-333 (II a) 19 Mir-Madjlessi S H, Farmer R G, Easley K A. et al . Colorectal and extracolonic malignancy in ulcerative colitis. Cancer. 1986; 58 1569-1574 (II b) 20 Prior P, Gyde S N, Macartney J C. et al . Cancer morbidity in ulcerative colitis. Gut. 1982; 23 490-497 (III) 21 Palli D, Trallori G, Saieva C. et al . General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence study. Gut. 1998; 42 175-179 (III) 22 Choi P M, Nugent F W, Schoetz D J. et al . Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993; 105 418-424 (III) 23 Connell W R, Talbot I C, Harpaz N. et al . Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994; 35 1419-1423 (II b) 24 Giardiello F M, Gurbuz A K, Bayless T M. et al . Colorectal cancer (crc) in ulcerative colitis (uc): Effect of a cancer prevention strategy on survival. Gastroenterology. 1993; 104 A-502 (III) 25 Jablonska M, Chlumska A. Management of cancer surveillance in ulcerative colitis. Gut. 1995; 37 A-90 (III/Suppl. 2) 26 Karlen P, Kornfeld D, Broström O. et al . Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998; 42 711-714 (III) 27 Melville D M, Jass J R, Shepherd N A. et al . Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Gastroenterology. 1988; 95 668-675 (II b) 28 Löfberg R, Broström O, Karlen P. et al . DNA aneuploidy in ulcerative colitis: Reproducibility, topographic distribution and relation to dysplasia. Gastroenterology. 1992; 102 1149-1154 (II b) 29 Rubin C E, Haggitt R C, Burmer G C. et al . DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992; 103 1611-1620 (II b) 30 Befrits R, Hammarberg C, Rubio C. et al . DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum. 1994; 37 313-319 (II b) 31 Connell W R, Lennard-Jones J E, Williams C B. et al . Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994; 107 934-944 (II b) 32 Grundfest S F, Fazio V, Weiss R A. et al . The risk of cancer following colectomy and ileorectal anastomosis for extensive mucosal ulcerative colitis. Ann Surg. 1981; 193 9-14 (III) 33 Kurtz L M, Flint G W, Platt M. et al . Carcinoma in the retained rectum after colectomy for ulcerative colitis. Dis Colon Rectum. 1980; 23 346-350 (IV) 34 Taylor B A, Pemberton J H, Carpenter H A. et al . Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance. Dis Colon Rectum. 1992; 35 950-956 (III) 35 Schmiegel W, Adler G, Frühmorgen P. et al . Kolorektales Karzinom: Prävention und Früherkennung in der asymptomatischen Bevölkerung - Vorsorge bei Risikopatienten - Endoskopische Diagnostik, Therapie und Nachsorge von Polypen und Karzinomen. Z Gastroenterol. 2000; 38 49-75 (IV) 36 Bernstein C N, Shanahan F, Weinstein W M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet. 1994; 343 71-74 (III) 37 Provenzale D, Kowdley K V, Arora S. et al . Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology. 1995; 109 1188-1196 (III) 38 Befrits R, Ljung T, Jaramillo E. et al . Low grade dysplasia in flat colonic mucosa in patients with extensive longstanding inflammatory bowel disease - a follow-up study. Gastroenterology. 1999; 116 A-376 (II b) 39 Brentnall T A, Bronner M P, Rubin C E. et al . Natural history and management of low-grade dysplasia in ulcerative colitis (uc). Gastroenterology. 1999; 116 A-382 (II b) 40 Rozen P, Baratz M, Fefer F. et al . Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology. 1995; 108 1361-1370 (II b)
